MaxCyte Inc (LSE:MXCT) - Share price - Overview


Stock Report

MaxCyte Inc MXCT

Last Price
GBX195.00

Day Change
7.50|4.00%

As of 20/03/2019
17:15:00 GMT | GBX
Minimum 15 Minutes Delay.

Last Close187.50p
Day Range192.20 - 197.40
Mkt Cap111.70Mil
52-Wk Range175.00 - 254.00
Yield %-
ISINUS57777K1060
Volume14,449
P/E-975.00
P/S6.77
P/CF-9.80

Share Price

Total Returns 20/03/2019

 Chg (%)  
More ...
MaxCyte Inc9.24 
FTSE 100 TR GBP1.58
 
Financials
201520162017
More ...
Income Statement
Turnover9.2912.2713.99
Operating Profit-0.76-2.72-9.29
Net Profit-1.45-3.35-9.92
Reported EPS-0.08-0.11-0.20
Balance Sheet
Current Assets6.1915.7930.55
Non Current Assets0.210.280.85
Total Assets6.4016.0731.40
Current Liabilities5.095.657.24
Total Liabilities---
Total Equity-48.365.0819.60
Cash Flow
Operating Cash Flow-0.18-2.34-9.68
Net Change in Cash-1.009.3213.62
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
19/03/2019Exercise of OptionDr. J. Stark Thompson PhD0.0025,0000.00
19/03/2019Sale of OptionDr. J. Stark Thompson PhD180.0025,00045,000.00
17/12/2018PurchaseMr. John Joseph Johnston81.5034,08327,778.00
26/07/2018PurchaseMr. John Joseph Johnston240.0011,50027,600.00

Company Profile

MaxCyte Inc is a provider of technological solutions to pharmaceutical companies. Its key product is electroporation technology which is sold to companies which are engaged in drug discovery and development.

Sector

Diagnostics & Research

Index

Next Event 30/04/2019

Final Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-38.46
Op Mrgn-0.66
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive Director, ChairmanDr. J. Stark Thompson PhD
Non-Executive DirectorMr. Stanley Charles Erck
Non-Executive DirectorDr. Richard H. Douglas, PhD
Non-Executive DirectorMr. Arthur Michael Mandell
Non-Executive DirectorMr. John Joseph Johnston
Executive Director, President and Chief Executive OfficerMr. Douglas Arthur Doerfler
Executive Director, Chief Financial Officer and Company SecretaryMr. Ronald Evan Holtz
Non-Executive DirectorMr. William Wade Brooke
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.